A Multicenter, Open-label, Metabolic Balance Study to Evaluate the Effects of Apraglutide on Intestinal Absorption in Adult Subjects With Short Bowel Syndrome, Intestinal Failure (SBS-IF), and Colon-in-Continuity (CIC)
Latest Information Update: 22 Aug 2024
At a glance
- Drugs Apraglutide (Primary)
- Indications Short bowel syndrome
- Focus Adverse reactions; Therapeutic Use
- Acronyms STARS Nutrition
- Sponsors VectivBio
- 01 May 2024 According to an Ironwood Pharmaceuticals media release, data from this study will be presented at 2024 Digestive Disease Week (DDW) meeting
- 23 Feb 2024 According to Ironwood Pharmaceuticals Media Release, apraglutide nutritional data from STARS Nutrition Phase 2 study will be presented at the American Society for Parenteral and Enteral Nutrition (ASPEN) 2024 Nutrition Science & Practice Conference. ASPEN is being held from March 2-5, 2024, in Tampa, Florida.
- 16 Oct 2023 According to Ironwood Pharmaceuticals Media Release, data from this study were presented during United European Gastroenterology (UEG) Week